New treatment approach shows promise in reducing prostate cancer spread
October 26, 2026
October 26, 2026
MONTREAL, Quebec, Oct. 26 -- McGill University posted the following news release:
* * *
New treatment approach shows promise in reducing prostate cancer spread
*
Adding darolutamide to standard treatment for aggressive prostate cancer reduced the risk of the disease spreading in an international Phase 3 trial.
"Our findings have the potential to influence the standard of care for patients with very high-risk prostate cancer wo . . .
* * *
New treatment approach shows promise in reducing prostate cancer spread
*
Adding darolutamide to standard treatment for aggressive prostate cancer reduced the risk of the disease spreading in an international Phase 3 trial.
"Our findings have the potential to influence the standard of care for patients with very high-risk prostate cancer wo . . .
